In our preliminary screening study on the protein tyrosine phosphatase 1B (PTP1B) inhibitory and cytotoxic activities, an ethyl acetate soluble fraction of the aerial part of Orthosiphon stamineus Benth. was found to inhibit PTP1B activity. Thus, based on assayguided isolation of this active fraction, ten compounds (1-10) were purified and evaluated for their inhibitory effects on PTP1B and their growth inhibition on MCF7, tamoxifen-resistant MCF7 (MCF7/TAMR), and MDA-MB-231 human breast cancer cell lines. Among the isolates, compounds 5, 6, 9, and 10 showed potencies against PTP1B with IC 50 values of 9.76, 10.12, 6.88, and 8.92 μM, respectively, followed by compounds 1 and 4 with IC 50 values of 16.92 and 22.25 μM. Kinetic study showed that the active compounds (1, 5, 9, and 10) possessed mixed-competitive inhibition, which was similar to the positive control (ursolic acid, IC 50 value of 3.42 μM, mixed-competitive). The others showed noncompetitive inhibition (4 and 6) . In addition, all these active compounds (1, 4-6, and 9-10 ) displayed growth inhibition on three cancer cell lines, especially the most PTP1B inhibitory flavanones (9 and 10) exhibited comparable inhibitory effects on MCF7, MCF7/TAMR, and MDA-MB-231 cancer cells (IC 50 values of 11.5 and 15.4, 8.9 and 10.5, and 17.6 and 21.3 μM, respectively) with tamoxifen, the positive control used in this assay (IC 50 values of 11.9, 12.1, and 12.7 μM, respectively). The results suggest that these active constituents from O. stamineus might be considered as new natural compounds for the development of anticancer agents via PTP1B inhibition.
Protein tyrosine phosphatase 1B (PTP1B) is a member of nontransmembrane protein tyrosine phosphatase that plays a key role in metabolic signaling and is a promising drug target for type 2 diabetes and obesity. 1, 2 Originally, this enzyme is located on the cytoplasmic face of endoplasmic reticulum, and is firstly identified from human placenta and executed as a critical regulator of multiple signaling pathways involved in many kinds of human cancers. 3, 4 Accumulating evidences indicated that PTP1B is involved in leptin signal of cancer as a key negative regulator. 3, 4 However, several contrasting findings suggested that it could exert both tumor-suppressing and tumorpromoting effects depending on the substrate involved and the cellular context. 5 Among human cancers, breast cancer is the most common malignancy and accounts for the second-highest number of deaths in women cancer worldwide. Protein tyrosine phosphatase 1B had recently drawn attention as an attractive target for the treatment of breast cancer. 5, 6 Protein tyrosine phosphatase 1B promoted breast cancer metastasis by regulating phosphatase and tensin homolog but not epithelial-mesenchymal transition. 7 In addition, the level of PTP1B was higher in breast cancer tissues than the corresponding adjacent normal tissues in several patients. It was positively associated with lymph node metastasis and estrogen receptor status, and acted as an independent prognostic factor and predicted a poor prognosis in estrogen receptor-positive breast cancer patients. 7, 8 These findings consequently raised the hypothesis that inhibitors of PTP1B may offer new avenues for the treatment of breast cancer. Therefore, finding new PTP1B inhibitors from natural plants was investigated. A few PTP1B inhibitors from natural products have been identified. The results showed that natural compounds found to inhibit PTP1B were diverse including pterocarpan derivatives, 9, 10 diterpenoids and triterpenoids, 11 flavonoids, 12 sesquiterpenoids, 12 coumarins, 12 alkaloids, 12 and phenolic compounds. 13, 14 These results encourage us to continue our studies in the discovery of PTP1B inhibitors from natural sources.
In our screening program for PTP1B inhibitors from medicinal plants, the ethyl acetate (EtOAc) fraction of the aerial parts of Orthosiphon stamineus Benth. (Lamiaceae) exhibited 67.8% inhibition on PTP1B at a concentration of 30 µg/mL. Orthosiphon stamineus is found mainly in Southeast Asia, Australia, and Africa. 15 In Vietnam, O. stamineus is called "Rau Meo" and the aerial parts are used for the treatment of urinary lithiasis, edema, eruptive fever, influenza, hepatitis, and jaundice. 16 In Myanmar, this plant is known as "Secho" or "Myitshwe" and the leaves are reputed to be an antidiabetic drug and decoctions of the air-dried leaves are used to cure urinary tract and renal diseases. 17 This plant is also known as "Neko no hige" in Japan and consumed as a healthy Java tea to facilitate body detoxification. In Indonesia, O. stamineus is known as an effective folk medicine for the treatment of diabetes, hypertension, rheumatism, tonsillitis, and menstrual disorder. 18 Orthosiphon stamineus had been reported to possess various pharmacological activities such as anti-inflammatory, 19, 20 antioxidant, 21 hepatoprotective, 22,23 anticancer, 24, 25 antihypertensive, 19, 26 gastroprotective, 22 antisebum, 27 hyperlipidemic, 28 nephroprotective, 21 antipyretic, 29 anti-angiogenic, 30 antibacterial, 31 antiviral, 32 diuretic, 33 and antidiabetic. 34, 35 Previous studies on chemical constituents of O. stamineus showed the presence of essential oils, 36 diterpenoids, triterpenoids, flavonoids, and phenolics. 19, 21, 37 Some studies have shown PTP1B inhibitory 34, 35 and cytotoxic activities 38 of extracts and fractions from O. stamineus. However, there has been no investigation of chemical constituents and inhibitory activities of PTP1B and cytotoxicity of O. stamineus. Therefore, this paper described the isolation and structural elucidation of these compounds as well as the evaluation of their PTP1B inhibitory and cytotoxic activities on human breast cancer cells.
The methanol extract of the aerial parts of O. stamineus was partitioned into chloroform, ethyl acetate, and water-soluble fractions. In a preliminary experiment, the inhibitory effect of these fractions was tested in vitro on PTP1B enzyme assay. The result showed that the ethylacetate fraction was the most active fraction against the enzyme activity (see supplemental figures S2-S4 for details). Therefore, the ethyl acetate fraction was selected for further isolation of active components. Chromatographic purification of this fraction (see supplemental figure S3 ) led to the isolation of 10 compounds (1-10) ( Figure 1) .
The 1 H-nuclear magnetic resonance (NMR) spectrum of 1, 2, 3, 5, and 6 displayed characteristic signals due to 5 aromatic protons of 2 benzene rings (rings A and B), together with those of hydroxyl (C-3) and methoxy groups (Figure 1 ), while their 13 C-NMR spectrum revealed the signals of a ketone (C-4), oxygen-substituted carbons, and 2 quaternary carbons ( Figure 1 ). The 1 H-and 13 C-NMR spectra indicated that these compounds are derivatives of kaempferol (for 1 and 2) and quercetin (for 3, 5, and 6). 39 Detailed analysis of the 1 H-and 13 C-NMR spectra of compound 1 revealed that 1 possessed 1 ketone carbon, 6 oxygenated carbons, and 2 methoxy carbons at C-7 and C-4′. Similar to compound 1, compound 2 also possessed 1 ketone carbon, 6 oxygenated carbons, but showed 3 methoxy carbons at C-5, C-7, and C-4′ ( Figure 1 ). Compound 3 possessed 1 ketone carbon, 7 oxygenated carbons, and 3 methoxy carbons at C-7, C-3′, and C-4′. Compound 5 also possessed 1 ketone carbon, 7 oxygenated carbons, and 4 methoxy carbons at C-5, C-7, C-3′, and C-4′. Similar to compound 2, compound 6 also possessed 1 ketone carbon, 3 methoxy carbons at C-5, C-7, and C-4′, but showed 7 oxygenated carbons ( Figure 1 ). Comparison of the 1 H-and 13 C-NMR data of these compounds with those published in the literature led to the identification structures of 1, 2, 3, 5, and 6 to be 7,4′-dimethylkaempferol, 40 5,7,4′-trimethylkaempferol, 41 7,3′,4′-trimethylquercetin, 42 5,7,3′,4′-tetramethylquercetin, 43 and 5,7,4′-trimethylquercetin, 44 respectively.
Compound 4 was isolated as a yellow crystal. Detailed analysis of the 1 H-and 13 C-NMR spectra of compound 4 revealed that 4 possessed 1 ketone carbon, 7 oxygenated carbons, and 4 methoxy carbons at C-3, C-5, C-3′, and C-4′ ( Figure 1 ). The 1 H-and 13 C-NMR spectra indicated that this compound possessed the basics of 3-methoxyflavone 39 and was also a derivative of quercetin. Thus, the structure of compound 4 was assigned to be 3,5,3′,4′-tetramethylquercetin. 45 Compound 7 was isolated as colorless needles. The 1 H-NMR spectrum of 7 displayed signals due to 6 methines and 4 methoxy groups at C-5, C-7, C-3′, and C-6′ ( Figure 1 ), while its 13 C-NMR spectrum revealed the signals of a ketone, 6 methine carbons, and 6 oxygen-substituted carbons (Figure 1) . The 1 H-and 13 C-NMR spectra indicated that 7 possessed the basics of flavone. 39 Analysis of these signals by the correlated spectroscopy (COSY) and heteronuclear multiple quantum correlation (HMQC) spectra led to the partial structures which were connected based on the longrange correlations observed in the heteronuclear multiple bond correlation (HMBC) spectrum. Thus, the structure of compound 7 was assigned to be 5,7,3′,6′-tetramethoxyflavone. 46 Compound 8 is a derivative compound of 7 in which the 1 H-and 13 C-NMR spectra were similar to those of 7 except for the presence of an aromatic proton at C-6′ and a methoxy group located at C-4′ in 2 ( Figure 1 ). Therefore, compound 8 was identified as 5,7,3′,4′-tetramethoxyflavone. 47 Compound 9 was isolated as yellow oil. The presence of an oxymethine group (C-2), a methylene group (C-3), and a carbonyl carbon (C-4) in the 1 H-and 13 C-NMR spectra indicated 9 to be a flavanone (Figure 1 ). 39 The 1 H-NMR spectrum of 9 showed signals of a 1,2,3,5,6-pentasubstituted benzene ring (ring A) and a 1,3,4-trisubstituted benzene ring (ring B) characterized with an ABX spin system ( Figure 1) . The 13 C-NMR spectrum exhibited 20 signals due to 12 sp 2 carbons of 2 benzene rings, a ketone, and 5 methoxy carbons ( Figure 1 ). The circular dichroism (CD) spectrum of compound 9 exhibited positive Cotton effect (∆ε 338 (nm) +4.7770) and negative Cotton effects (∆ε 290 (nm) -59.8223), which established the absolute configuration at C-2 to be 2S (see supplemental figure  S5 ). Based on these evidences and in comparison with the published data, compound 9 was identified as 2S-5,6,7,3′,4′-pentamethoxyflavanone. 48 Similar to 9, compound 10 also possessed 1 ketone carbon, but showed 7 oxygenated carbons and 4 methoxy carbons at C-5, C-7, C-3′, and C-4′ ( Figure 1 ). Analysis of these signals by the COSY, HMQC, and HMBC spectra led to the partial structures of 10. Compound 10 exhibited positive Cotton effect (∆ε 337 (nm) +9.8024) and negative Cotton effects (∆ε 284 (nm) -68.4875) in its CD spectrum (see supplemental figure S6 ). Therefore, compound 10 was identified as 2S-5′-hydroxy-5,7,3′,4′-tetramethoxyflavanone. 49 All isolates 1 to 10 were evaluated for their inhibitory activity against the PTP1B enzyme activity using in vitro assay, and the results are presented in Table 1 as IC 50 values. Among these isolates, compounds 5, 6, 9, and 10 displayed the most potency with IC 50 values of 9.76 ± 0.67, 10.12 ± 1.09, 6.88 ± 0.76, and 8.92 ± 0.72 µM, respectively, followed by compounds 1 and 4 with IC 50 values of 16.92 ± 2.12 and 22.25 ± 1.70 µM. The remaining compounds were less active with IC 50 values > 30 µM (Table 1) . Among these methoxylated flavonoids, the flavanones (9 and 10) possessed the strongest activity (IC 50 < 10 µM), the flavonols (1-6) possessed significant activity (IC 50 ranging from 9.82 to 22.25 µM), and the flavones (7 and 8) were inactive (IC 50 >30 µM). Ursolic acid was used as a positive control in this assay and displayed an IC 50 value of 3.42 ± 0.45 µM and mixed-competitive inhibition mode. It showed 2 times stronger PTP1B inhibition than compound 9, 3 times than compounds 5, 6, and 10 as well as 5 and 7 times stronger PTP1B inhibition than compounds 1 and 4, respectively ( Table 1) .
The Lineweaver-Burk plot and Dixon plot experiments were performed with the presence and absence of the inhibitors with various concentrations of the substrate para-Nitrophenylphosphate (p-NPP) to determine the inhibition type of the active compounds (1, 4-6, and 9-10). The double reciprocal Lineweaver-Burk plot (Figure 2 ) and the Dixon plot ( Figure 3) data were analyzed by using the Sigma plot program (SPCC Inc., Chicago, IL, United States). Table 1 listed the K i values of the active compounds which were determined by Dixon plot experiment analysis (Figure 3 ). The inhibition type of the active compounds (1, 4-6, and 9-10) was listed in Table 1 as determined by the Lineweaver-Burk plot experiment ( Figure 2 ). Of these active flavonoids, compounds 1, 5, 9, and 10, as well as the positive control (ursolic acid), exhibited mixed-competitive inhibition (the lines intersected at a value upper to the yaxis and under zero on the xaxis), while compounds 4 and 6 exhibited noncompetitive inhibition types because the lines intersected at a value of 1/[S] under zero on the xaxis (1/(intensity/min) =0) ( Figure 2) .
For diabetic and cancer objects, the PTP1B enzyme displayed an important role as an attractive target in the treatment, especially for breast cancer. Many studies have shown that in human breast cancer PTP1B was overexpressed, and that the inhibition of PTP1B delayed erbB2-induced mammary tumorigenesis and protected from lung metastasis. 6, 50 Thus, the isolated flavonoids were further investigated for their growth inhibition on MCF7, MCF7/TAMR, and MDA-MB-231 breast cancer cell lines ( Table 2) . Among the isolates, compounds 5, 6, 9, and 10 which potentially inhibited PTP1B (Table 1 ) also displayed potency against these 3 cancer cell lines. Especially, compound 9 which was the most PTP1B inhibitor (IC 50 value of 6.88 ± 0.76 µM) also showed the most cytotoxicity against MCF7 and MCF7/TAMR (IC 50 values of 11.5 ± 0.7 and 8.9 ± 1.0 µM, respectively) when compared with positive control (tamoxifen, IC 50 values of 11.9 ± 0.4 and 12.1 ± 0.7 µM, respectively). In the same manner, flavanones (9 and 10) were the most active compounds on MCF7/TAMR and MDA-MB-231 cell lines, followed by flavonols 1, 5, and 6, and then the worst compounds 2 and 3 and flavones 7 and 8 (see also Figure 1 and Table 2 for more details). However, this rule was irregular for the cytotoxic activity of these isolates on MCF7 human cancer cell lines. Interestingly, in this study, we found that flavanones (9 and 10) bearing the more methoxy moiety in the structure exhibited the stronger inhibitory effect on both PTP1B and human breast cancer cells. From our research data, we might suggest that the polymethoxylated flavanones 9 and 10 isolated from Vietnamese cat's whisker (O. stamineus Benth.) can be considered as new natural compounds for the development of anticancer agents via PTP1B inhibition. (5, 6, 9, and 10) used for determining the inhibition constant K i . K i values were determined from the negative xaxis value at the point of the intersection of 3 lines. Data are expressed as the mean reciprocal of initial velocity for n = 3 replicates at each substrate concentration. size), J. sphere ODS-H80 (20 × 150 mm, 4 µm particle size) RS Tech, Korea, and Shodex-C18M-10E (10 × 250 mm, 10 µm particle size), and/or YMC-Pak ODS-AM (6.0 × 150 mm, 5 µm particle size) for semipreparative runs.
Plant Materials
The aerial parts of O. stamineus Benth. were collected in January 2017 at Ngu Hiep, Thanh Tri, Ha Noi. The sample was identified by Dr Nguyen Quoc Binh (Viet Nam National Museum of Nature, VAST). A voucher specimen (SH-164) was deposited at the Institute of Natural Products Chemistry (INPC), VAST (see supplemental figure S1 and supplemental references S1-S2 for details).
Extraction and Isolation
The aerial parts of O. stamineus (1.1 kg) were extracted with methanol (5 L × 3 times) at room temperature using sonication for 5 hours. After removing the solvent under reduced pressure, the methanol extract (121 g) was suspended in hot water (500 mL) and partitioned with nhexane (1 L × 3), chloroform (CHCl 3 , 1 L × 3), and ethylacetate (EtOAc, 1 L × 3), successively. The resulting fractions were concentrated in vacuo to give the hexane, CHCl 3 , and EtOAc-soluble fractions, respectively. By the guided-fractionation activity, the EtOAc-soluble fraction (43. . Fraction 3 (OA-3) (650 mg) was also subjected onto an open silica gel column chromatography (4.0 × 60 cm; SiO 2 , 40-63 mm particle size), eluted with a stepwise gradient solvent system of nhexane/acetone (from 10:1 to 1:0) to afford 6 subfractions (OA-3.1-OA-3.6). Compounds 7 (4.9 mg; t R = 10.1 minutes), 2 (5.8 mg; t R = 12.5 minutes), and 8 (4.4 mg; t R = 14.5 minutes) were isolated from subfraction OA-3.2 (69 mg) by Gilson HPLC system, using an isocratic solvent system of 50% ACN in H 2 O + 0.1% formic acid, flow rate was set as 2 mL/ min, over 20 minutes; UV detections at 205 and 254 nm; RS Tech Optima Pak C 18 column (10 × 250 mm, 10 µm particle size). Further purification of subfraction OA-3.2 (35 mg) by semipreparative Gilson HPLC system with a RS Tech Optima Pak C 18 column (10 × 250 mm, 10 µm particle size), eluted with an isocratic solvent system of 50% MeCN in H 2 O + 0.1% formic acid (flow rate = 2 mL/min), over 40 minutes; UV detections at 205 and 254 nm resulted in the isolation of compound 6 (5.3 mg; t R = 36.3 minutes). The subfraction OA-3.4 (55 mg) was also purified by semipreparative Gilson HPLC using same column and flow rate with 60% ACN in H 2 O + 0.1% formic acid over 25 minutes to give compounds 9 (4.0 mg; t R = 16.6 minutes), 10 (3.5 mg; t R = 18.6 minutes), and 3 (1.5 mg; t R = 21.6 minutes), respectively.
Protein Tyrosine Phosphatase 1B Inhibition Assay
Protein tyrosine phosphatase 1B (human recombinant) was purchased from Biomol International LP, Plymouth Meeting, PA, United States, and the inhibitory activities of the tested samples were evaluated using the method as described. 51 Briefly, 0.05 to 0.1 µg of PTP1B (BIOMOL International L.P., Plymouth Meeting, PA, United States) and 4 mM p-NPP in a buffer containing 1 mM dithiothreitol, 0.1 M NaCl, 1 mM EDTA, and 50 mM citrate (pH 6.0), with or without test compounds, were added as 100 µL of a final volume to each of the 96 well. After the reaction mixture was incubated at 37°C for 30 minutes, 10 M NaOH was added to quench the reaction. Protein tyrosine phosphatase 1B enzyme activity was determined by the amount of produced pnitrophenol at 405 nm. The nonenzymatic hydrolysis of the substrate was corrected by measuring the control, which did not contain PTP1B enzyme.
Determination of the Inhibition Mode of Active Compounds
The Lineweaver-Burk plot and Dixon plot experiments were carried out in the presence and absence of the inhibitors with 
Cytotoxic Activity Assay
The cancer cell lines were maintained in Roswell Park Memorial Institute (RPMI) 1640, which included l-glutamine with 10% fetal bovine serum (FBS) and 2% penicillin-streptomycin. Cells were cultured at 37°C in a 5% CO 2 incubator. Cytotoxic activity was measured using a modified 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide (MTT) assay. 52 Viable cells were seeded in the growth medium (100 µL) into 96-well microtiter plates (1 × 10 4 cells per well) and incubated at 37°C in a 5% CO 2 incubator. The test sample was dissolved in dimethyl sulfoxide (DMSO) and adjusted to final sample concentrations ranging from 5.0 to 150 µM by diluting with the growth medium. Each sample was prepared in triplicate. The final DMSO concentration was adjusted to <0.1%. After standing for 24 hours, 10 µL of the test sample was added to each well. The same volume of DMSO was added to the control wells. On removing medium after 48 hours of the test sample treatment, MTT (5 mg/mL, 10 µL) was also added to the each well. After 4 hours incubation, the plates were removed and the resulting formazan crystals were dissolved in DMSO (150 µL). The OD was measured at 570 nm. The IC 50 value was defined as the concentration of sample that reduced absorbance by 50% relative to the vehicle-treated control.
Statistical Analysis
Data are represented as means ± SD of at least 3 independent experiments performed in triplicated assays and determined by regression analysis. For statistical analysis of the data for single comparison, the significance between means was determined by Student's t test. Sigma Plot program version 11.0 was used for analysis of the kinetic data.
